Experience
Roger Franklin (born 1979) holds a Ph.D. in oncology from the University of Cambridge. Roger has more than 15 years of experience from the life science industry, including positions as senior analyst in pharmaceuticals and biotech at a London-based investment bank and as investment manager at a large London-based life science venture capital fund. Roger currently serves as Partner at Hadean Ventures, a Stockholm/Oslo-based European life science venture fund.

Other assignments
Board Director of Abliva AB (Sweden) and TargED Biopharmaceuticals BV (Netherlands)
Board Observer at Pipeline Therapeutics Inc, San Diego (USA), Step Pharma SAS (France), Emergence Therapeutics AG (Germany), and Cardior Pharmaceuticals GmbH (Germany)

Experience
Charlotte Edenius (born 1958), M.D, Ph.D., is one of the co-founders of Gesynta Pharma. Charlotte has more than 25 years of experience from positions within the life science industry with experience from all phases of drug development as well as business development including successful partnering and licensing. Her experience spans from AstraZeneca to biotech companies including senior management positions as EVP R&D, Medivir AB, SVP Research, Orexo AB, and CSO, Biolipox AB. Charlotte has also served in non-executive board positions in several private and public pharma companies, including Karolinska Development AB.

Other assignments
Board Director of Kancera AB (publ)
Chairman of the Board and CEO of Allmora Life Science AB

Experience
Jonas Jendi (born 1970) holds an M.Sc. from the Stockholm School of Economics. Jonas joined Industrifonden in 2017. Jonas has been focused on the commercialization of life science innovation for about 20 years. Between 2001 and 2010, Jonas was the CEO of Cogmed, a start-up in the field of evidence-based cognitive training. Before joining Industrifonden, Jonas also held various advisor and board member roles in both early stage and public companies, and across digital health, medtech and biotech. Jonas is currently Practice Lead Life Science and Senior Investment Director at Industrifonden, where he also serves as COO.

Other assignments
Board Director of Airsonett AB, Asgard Therapeutics AB, Avidicare AB, Elypta AB, and Smartfish AS (Norway)

Experience
Pekka Simula (born 1974) holds an M.Sc. in Physics from Helsinki University of Technology. Pekka has more than 25 years of experience with innovative startups in health and life sciences, including digitalization of data capture in clinical trials, cancer radiotherapy, and as founder and CEO in oncology and CNS drug development companies. Pekka currently serves as Partner at Innovestor Life Science, a Helsinki-based life science venture fund.

Other assignments
Chairman of the Board of Soihtu DTx, Kasvu Therapeutics, and HVR Cardio Oy
Board Director of Neurotar Oy Ltd